세계의 헬스케어 양자 컴퓨팅 시장 : 컴포넌트별, 전개 형태별, 기술별, 용도별, 최종사용자별, 지역별 - 예측(-2030년)

The global quantum computing in healthcare market is projected to reach USD 1,324.2 million by 2030 from USD 265.9 million in 2025 at a high CAGR of 37.9% during the forecast period. The quantum computing market in healthcare is steadily advancing due to the pressing need to improve drug discovery, enhance clinical decision-making, and increase diagnostic accuracy. As healthcare data becomes more complex and voluminous, quantum computing offers powerful tools for simulation, modeling, and advanced data processing that surpass traditional systems. These solutions are expected to significantly reduce research timelines and costs while also facilitating the development of more targeted and personalized treatments.

The growth of this market is further supported by increasing funding for quantum startups, government-backed research initiatives, and collaborative efforts between academia and industry. However, the sector faces challenges, particularly regarding the accuracy of quantum systems and the high costs associated with their implementation, which continue to hinder widespread adoption.

"The superconducting qubits segment is expected to be the largest segment during the forecast period."

In 2024, superconducting qubits emerged as the largest segment in the quantum computing market for healthcare and are expected to maintain this position in the coming years. This dominance is driven by their maturity, scalability potential, and strong performance in executing complex computational tasks.

Superconducting qubit systems offer high-speed processing capabilities, making them well-suited for healthcare applications such as molecular simulations, genomic analysis, and drug discovery. These systems are also compatible with cloud-based quantum platforms, allowing researchers and clinicians broader access without the need for extensive on-premises infrastructure.

As the demand for more efficient tools to handle biomedical data and accurately model biological systems grows, superconducting qubit technology is increasingly being adopted in healthcare-focused quantum initiatives. Continued advancements in coherence times, error correction, and integration with hybrid computing frameworks further reinforce their role as a foundational technology for accelerating innovation in healthcare.

"Healthcare payers are expected to be the fastest-growing segment in the quantum computing in healthcare market, by end user, during the forecast period."

Healthcare payers have emerged as the fastest-growing end-user group in the quantum computing in healthcare market. This trend is driven by the increasing need for advanced data processing tools to manage healthcare costs, assess patient risks, and support personalized coverage plans. Quantum computing enables quicker analysis of complex datasets, allowing payers to enhance risk prediction, detect anomalies, and develop value-based reimbursement models. As the healthcare industry shifts toward data-driven decision-making, payers are adopting quantum technologies to improve operational efficiency, reduce fraud, and gain deeper insights into treatment outcomes and population health.

"Asia Pacific is expected to witness the highest growth rate during the forecast period."

The Asia Pacific region is projected to experience the fastest growth in the quantum computing in healthcare market during the forecast period. This growth is driven by increasing government support for quantum technology, a rise in research collaborations, and a surge in funding for emerging tech startups. Countries in the region are prioritizing quantum innovation through national strategies and investments, establishing a strong foundation for the application of these technologies in healthcare.

As the burden of chronic diseases grows, there is an increased focus on utilizing quantum computing for tasks such as drug research, genetic analysis, and complex data modeling. Additionally, enhanced digital infrastructure and wider access to cloud-based quantum platforms are facilitating faster adoption. Collectively, these factors are positioning Asia Pacific as a key hub for advancements in quantum healthcare.

The breakdown of primary participants is as mentioned below:

• By Company Type: Tier 1 (45%), Tier 2 (30%), and Tier 3 (25%)
• By Designation: Directors (42%), Managers (31%), and Others (27%)
• By Region: North America (32%), Europe (26%), Asia Pacific (32%), the Middle East & Africa (5%), and Latin America (5%)

Key Players in the Quantum Computing in Healthcare Market

The key players operating in the quantum computing in healthcare market include Rigetti & Co, LLC (US), IBM (US), D-Wave Quantum Inc. (Canada), Microsoft (US), IonQ (US), Quantinuum, Ltd. (US & UK), Google, Inc. (US), Atos SE (France), QC Ware (California), Classiq Technologies, Inc. (US), Xanadu Quantum Technologies Inc. (Canada), Hefei Origin Quantum Computing Technology Co., Ltd. (China), Protiviti, Inc. (US), Quandela (France), Deloitte (UK), Accenture (Ireland), Amazon Web Services (AWS) (US), Fujitsu (Japan), Qnami (Switzerland), SEEQC (US), SandboxAQ (US), Pasqal (France), Qubit Pharmaceuticals (France), Polaris Quantum Biotech (US), and QSimulate (US).

Research Coverage

The report analyzes the quantum computing in healthcare market and estimates the market size and future growth potential of various market segments based on component, deployment, application, technology, end user, and region. It also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

• Analysis of key drivers (increasing investments in quantum computing in developed as well as emerging economies, growing inclination of payers toward quantum computing, rising demand for personalized medicine, increasing funding and investments in quantum computing startups, and rising need to reduce time and cost of drug discovery and development), restraints (accuracy issues with quantum computing systems and high implementation costs), opportunities (technological advancements in quantum computing supporting various healthcare applications and potential applications in medical image analysis and oncology), and challenges (lack of technical expertise & data management issues) influencing the growth of the quantum computing in healthcare market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the quantum computing in healthcare market.
• Market Development: Comprehensive information on the lucrative emerging markets. The report analyzes the market for various types of quantum computing in healthcare solutions across regions.
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the quantum computing in healthcare market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the quantum computing in healthcare market, like Rigetti & Co, LLC (US), IBM (US), D-Wave Quantum Inc. (Canada), Microsoft (US), and IonQ (US).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 LIMITATIONS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH APPROACH
  • 2.1.1 SECONDARY RESEARCH
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY RESEARCH
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key data from primary sources
    • 2.1.2.3 Breakdown of primaries
    • 2.1.2.4 Insights from primary experts
• 2.2 RESEARCH METHODOLOGY DESIGN
• 2.3 MARKET SIZE ESTIMATION
• 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.5 MARKET SHARE ESTIMATION
• 2.6 STUDY ASSUMPTIONS
• 2.7 RESEARCH LIMITATIONS
  • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
• 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 OVERVIEW OF QUANTUM COMPUTING IN HEALTHCARE MARKET
• 4.2 ASIA PACIFIC: QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT
• 4.3 GEOGRAPHIC SNAPSHOT OF QUANTUM COMPUTING IN HEALTHCARE MARKET
• 4.4 REGIONAL MIX: QUANTUM COMPUTING IN HEALTHCARE MARKET
• 4.5 QUANTUM COMPUTING IN HEALTHCARE MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 MARKET DRIVERS
    • 5.2.1.1 Increasing investments in quantum computing in developed as well as emerging economies
    • 5.2.1.2 Growing inclination of payers toward quantum computing
    • 5.2.1.3 Rising demand for personalized medicine
    • 5.2.1.4 Increasing funding and investments in quantum computing startups
    • 5.2.1.5 Rising need to reduce time and cost of drug discovery and development
  • 5.2.2 MARKET RESTRAINTS
    • 5.2.2.1 Accuracy issues with quantum computing systems and high implementation costs
  • 5.2.3 MARKET OPPORTUNITIES
    • 5.2.3.1 Technological advancements in quantum computing for various healthcare applications
    • 5.2.3.2 Potential applications in medical image analysis and oncology
  • 5.2.4 MARKET CHALLENGES
    • 5.2.4.1 Lack of technical expertise and data management issues
• 5.3 INDUSTRY TRENDS
  • 5.3.1 HYBRID QUANTUM-CLASSICAL COMPUTING
  • 5.3.2 QUANTUM MACHINE LEARNING
  • 5.3.3 GROWING NUMBER OF APPLICATIONS IN HEALTHCARE INDUSTRY
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Artificial intelligence and machine learning integration
    • 5.4.1.2 Quantum communication technology
  • 5.4.2 COMPLEMENTARY TECHNOLOGIES
    • 5.4.2.1 Blockchain
    • 5.4.2.2 Digital twins
  • 5.4.3 ADJACENT TECHNOLOGIES
    • 5.4.3.1 Precision medicine
• 5.5 PORTER'S FIVE FORCES ANALYSIS
  • 5.5.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.5.2 BARGAINING POWER OF SUPPLIERS
  • 5.5.3 BARGAINING POWER OF BUYERS
  • 5.5.4 THREAT OF NEW ENTRANTS
  • 5.5.5 THREAT OF SUBSTITUTES
• 5.6 REGULATORY ANALYSIS
  • 5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.6.2 REGULATORY STANDARDS
    • 5.6.2.1 P1913 - Software-defined quantum communication
    • 5.6.2.2 P7130 - Standard for quantum technologies definitions
    • 5.6.2.3 P7131 - Standard for quantum computing performance metrics and benchmarking
• 5.7 VALUE CHAIN ANALYSIS
  • 5.7.1 RESEARCH, DESIGN, AND DEVELOPMENT
  • 5.7.2 MANUFACTURERS & SERVICE PROVIDERS
  • 5.7.3 MARKETING & SALES EXECUTIVES
  • 5.7.4 END USERS
• 5.8 ECOSYSTEM ANALYSIS
• 5.9 PATENT ANALYSIS
  • 5.9.1 PATENT PUBLICATION TRENDS QUANTUM COMPUTING IN HEALTHCARE MARKET
  • 5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS
• 5.10 CASE STUDY ANALYSIS
• 5.11 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.11.2 BUYING CRITERIA
• 5.12 KEY CONFERENCES & EVENTS (2025-2026)
• 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.14 IMPACT OF 2025 US TARIFF ON QUANTUM COMPUTING IN HEALTHCARE MARKET
  • 5.14.1 INTRODUCTION
  • 5.14.2 KEY TARIFF RATES
  • 5.14.3 PRICE IMPACT ANALYSIS
  • 5.14.4 IMPACT ON COUNTRY/REGION
    • 5.14.4.1 US
    • 5.14.4.2 Europe
    • 5.14.4.3 Asia Pacific
  • 5.14.5 IMPACT ON END USERS
    • 5.14.5.1 Pharmaceutical & biotechnology companies
    • 5.14.5.2 Labs & research institutes
    • 5.14.5.3 Healthcare providers
    • 5.14.5.4 Healthcare payers

6 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY COMPONENT

• 6.1 INTRODUCTION
• 6.2 SOFTWARE
  • 6.2.1 SHIFT TO WEB/CLOUD-BASED MODELS TO SUPPORT GROWTH
• 6.3 HARDWARE
  • 6.3.1 NEED FOR FREQUENT HARDWARE UPGRADES TO DRIVE MARKET GROWTH
• 6.4 SERVICES
  • 6.4.1 INTRODUCTION OF COMPLEX SOFTWARE TO DRIVE DEMAND FOR SERVICES

7 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY DEPLOYMENT

• 7.1 INTRODUCTION
• 7.2 ON-PREMISE SOLUTIONS
  • 7.2.1 RISING DEPLOYMENT OF ON-PREMISE QUANTUM COMPUTERS BY ORGANIZATIONS TO ENSURE DATA SECURITY
• 7.3 CLOUD-BASED SOLUTIONS
  • 7.3.1 INCREASING PREFERENCE FOR CLOUD-BASED QUANTUM COMPUTING FOR RESEARCH & DEVELOPMENT TO SUPPORT MARKET GROWTH

8 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY TECHNOLOGY

• 8.1 INTRODUCTION
• 8.2 SUPERCONDUCTING QUBITS
  • 8.2.1 LOW POWER CONSUMPTION, HIGH SPEED, AND ABILITY TO OPERATE AT LOW TEMPERATURES TO DRIVE MARKET
• 8.3 TRAPPED IONS
  • 8.3.1 SUPERIOR CONNECTIVITY AND HIGHER GATE FIDELITY TO DRIVE MARKET
• 8.4 QUANTUM ANNEALING
  • 8.4.1 QUICK DISCOVERY OF MOST EFFICIENT CONFIGURATIONS AMONG POSSIBLE COMBINATIONS OF VARIABLES TO DRIVE MARKET
• 8.5 QUANTUM MACHINE LEARNING
  • 8.5.1 ABILITY OF QML TO ACCELERATE HEALTHCARE INNOVATION THROUGH NEXT-GEN INTELLIGENCE TO BOOST MARKET
• 8.6 OTHER TECHNOLOGIES

9 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY APPLICATION

• 9.1 INTRODUCTION
• 9.2 DRUG DISCOVERY & DEVELOPMENT
  • 9.2.1 ENABLING ACCURATE DATA PROJECTIONS AND SOLUTIONS FOR DRUG DISCOVERY AND DEVELOPMENT TO BOOST MARKET GROWTH
• 9.3 MEDICAL DIAGNOSTICS
  • 9.3.1 PRECISE AND SENSITIVE MEDICAL DIAGNOSTIC PROCEDURES TO DRIVE MARKET
• 9.4 GENOMICS & PRECISION MEDICINE
  • 9.4.1 UNLOCKING POWER OF GENOMICS & PRECISION MEDICINE WITH QUANTUM COMPUTING TECHNOLOGY TO SUPPORT MARKET GROWTH
• 9.5 RADIOTHERAPY
  • 9.5.1 MORE PERSONALIZED AND PRECISE TREATMENT IN FIGHT AGAINST CANCER TO FUEL GROWTH
• 9.6 RISK ANALYSIS
  • 9.6.1 ENHANCED PRICING MODEL MANAGEMENT AND DECREASED COSTS ASSOCIATED WITH FRAUD TO BOOST ADOPTION IN RISK ANALYSIS
• 9.7 HEALTHCARE LOGISTICS & SCHEDULING
  • 9.7.1 ENHANCED OPERATIONAL EFFICIENCY AND REDUCED SCHEDULING BOTTLENECKS IN HEALTHCARE DELIVERY TO DRIVE DEMAND
• 9.8 CYBERSECURITY & DATA ENCRYPTION
  • 9.8.1 SECURE PATIENT DATA WITH QUANTUM-RESISTANT ENCRYPTION AND ULTRA-SAFE COMMUNICATION PROTOCOLS TO PROPEL DEMAND
• 9.9 OTHER APPLICATIONS

10 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.2.1 RISING DEMAND FOR SOLUTIONS TO REDUCE TIME AND COSTS OF DRUG DEVELOPMENT TO DRIVE GROWTH
• 10.3 LABS & RESEARCH INSTITUTES
  • 10.3.1 INCREASED RESEARCH ACTIVITIES TO ENCOURAGE USE OF AI IN GENOMICS IN ACADEMIC AND GOVERNMENT INSTITUTES
• 10.4 HEALTHCARE PROVIDERS
  • 10.4.1 IMPROVED PATIENT MANAGEMENT, LOWERED COSTS, AND ABILITY TO DELIVER BETTER PATIENT TREATMENT TO BOOST DEMAND
• 10.5 HEALTHCARE PAYERS
  • 10.5.1 POTENTIAL TO REDUCE READMISSIONS AND OVERHEAD COSTS TO DRIVE ADOPTION

11 QUANTUM COMPUTING IN HEALTHCARE MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 Expanding applications of quantum computing in healthcare to bolster market growth
  • 11.2.3 CANADA
    • 11.2.3.1 Investments and developments in quantum computing industry to drive market
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 Collaborations & partnerships to drive adoption of quantum computing solutions
  • 11.3.3 UK
    • 11.3.3.1 Increased focus on quantum computing applications to support growth
  • 11.3.4 FRANCE
    • 11.3.4.1 Government funding for quantum computing to bolster growth
  • 11.3.5 ITALY
    • 11.3.5.1 Advances in quantum healthcare with supercomputing integration and next-gen biomedical research to boost market
  • 11.3.6 SPAIN
    • 11.3.6.1 Strong government support to boost market in Spain
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 JAPAN
    • 11.4.2.1 Rising penetration of technologies to support market growth
  • 11.4.3 CHINA
    • 11.4.3.1 China to dominate quantum computing in healthcare market in Asia Pacific
  • 11.4.4 INDIA
    • 11.4.4.1 Emerging real-world use cases to drive demand in India
  • 11.4.5 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Rising adoption of quantum technologies to drive healthcare innovation in Brazil
  • 11.5.3 MEXICO
    • 11.5.3.1 Mexico to pave the way for quantum healthcare innovation
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 11.6.2 GCC COUNTRIES
    • 11.6.2.1 Advancing healthcare in GCC through quantum computing to drive growth
  • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN QUANTUM COMPUTING IN HEALTHCARE MARKET
• 12.3 REVENUE ANALYSIS, 2020-2024
• 12.4 MARKET SHARE ANALYSIS, 2024
• 12.5 MARKET RANKING ANALYSIS
• 12.6 COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2024
  • 12.6.1 STARS
  • 12.6.2 EMERGING LEADERS
  • 12.6.3 PERVASIVE PLAYERS
  • 12.6.4 PARTICIPANTS
  • 12.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 12.6.5.1 Company footprint
    • 12.6.5.2 Region footprint
    • 12.6.5.3 Component footprint
    • 12.6.5.4 Application footprint
    • 12.6.5.5 Technology footprint
    • 12.6.5.6 Deployment footprint
    • 12.6.5.7 End-user footprint
• 12.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 12.7.1 PROGRESSIVE COMPANIES
  • 12.7.2 RESPONSIVE COMPANIES
  • 12.7.3 DYNAMIC COMPANIES
  • 12.7.4 STARTING BLOCKS
  • 12.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 12.7.5.1 Detailed list of key startups/SMEs
    • 12.7.5.2 Competitive benchmarking of startups/SMEs
• 12.8 COMPANY VALUATION & FINANCIAL METRICS
  • 12.8.1 FINANCIAL METRICS
  • 12.8.2 COMPANY VALUATION
• 12.9 BRAND/SOFTWARE COMPARISON
• 12.10 COMPETITIVE SCENARIO
  • 12.10.1 PRODUCT & SERVICE LAUNCHES
  • 12.10.2 DEALS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 RIGETTI & CO, LLC.
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products & services offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product launches
      • 13.1.1.3.2 Deals
      • 13.1.1.3.3 Other developments
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses & competitive threats
  • 13.1.2 IBM
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products & services offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Product launches
      • 13.1.2.3.2 Deals
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Key strengths
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses & competitive threats
  • 13.1.3 D-WAVE QUANTUM INC.
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products & services offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product launches
      • 13.1.3.3.2 Deals
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Key strengths
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses & competitive threats
  • 13.1.4 MICROSOFT
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products & services offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product launches
      • 13.1.4.3.2 Deals
    • 13.1.4.4 MnM view
      • 13.1.4.4.1 Key strengths
      • 13.1.4.4.2 Strategic choices
      • 13.1.4.4.3 Weaknesses & competitive threats
  • 13.1.5 IONQ
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products & services offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Product launches
      • 13.1.5.3.2 Deals
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Key strengths
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses & competitive threats
  • 13.1.6 QUANTINUUM LTD.
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products & services offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product launches
      • 13.1.6.3.2 Deals
  • 13.1.7 GOOGLE LLC
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products & services offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Product launches
      • 13.1.7.3.2 Deals
    • 13.1.7.4 MnM view
      • 13.1.7.4.1 Key strengths
      • 13.1.7.4.2 Strategic choices
      • 13.1.7.4.3 Weaknesses & competitive threats
  • 13.1.8 ATOS SE
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products & services offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Product launches
      • 13.1.8.3.2 Deals
  • 13.1.9 QC WARE
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products & services offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product launches
      • 13.1.9.3.2 Deals
  • 13.1.10 CLASSIQ TECHNOLOGIES LTD.
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products & services offered
    • 13.1.10.3 Recent developments
      • 13.1.10.3.1 Deals
  • 13.1.11 XANADU QUANTUM TECHNOLOGIES INC.
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products & services offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Product launches
      • 13.1.11.3.2 Deals
  • 13.1.12 HEFEI ORIGIN QUANTUM COMPUTING TECHNOLOGY CO., LTD.
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products & services offered
    • 13.1.12.3 Recent developments
      • 13.1.12.3.1 Product launches
      • 13.1.12.3.2 Deals
  • 13.1.13 PROTIVITI INC.
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products & services offered
  • 13.1.14 QUANDELA
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products & services offered
    • 13.1.14.3 Recent developments
      • 13.1.14.3.1 Product launches
      • 13.1.14.3.2 Deals
  • 13.1.15 DELOITTE
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products & services offered
    • 13.1.15.3 Recent developments
      • 13.1.15.3.1 Deals
  • 13.1.16 ACCENTURE
    • 13.1.16.1 Business overview
    • 13.1.16.2 Products & services offered
    • 13.1.16.3 Recent developments
      • 13.1.16.3.1 Deals
  • 13.1.17 AMAZON WEB SERVICES (AWS)
    • 13.1.17.1 Business overview
    • 13.1.17.2 Products & services offered
    • 13.1.17.3 Recent developments
      • 13.1.17.3.1 Product & service launches
      • 13.1.17.3.2 Deals
    • 13.1.17.4 MnM view
      • 13.1.17.4.1 Key strengths
      • 13.1.17.4.2 Strategic choices
      • 13.1.17.4.3 Weaknesses & competitive threats
  • 13.1.18 FUJITSU
    • 13.1.18.1 Business overview
    • 13.1.18.2 Product & services offered
    • 13.1.18.3 Recent developments
      • 13.1.18.3.1 Product launches
      • 13.1.18.3.2 Deals
  • 13.1.19 QNAMI
    • 13.1.19.1 Business overview
    • 13.1.19.2 Products & services offered
    • 13.1.19.3 Recent developments
      • 13.1.19.3.1 Product launches
      • 13.1.19.3.2 Deals
      • 13.1.19.3.3 Expansions
  • 13.1.20 SEEQC
    • 13.1.20.1 Business overview
    • 13.1.20.2 Product & services offered
    • 13.1.20.3 Recent developments
      • 13.1.20.3.1 Product launches
      • 13.1.20.3.2 Deals
• 13.2 OTHER PLAYERS
  • 13.2.1 SANDBOX AQ
  • 13.2.2 PASQAL
  • 13.2.3 QUBIT PHARMACEUTICALS
  • 13.2.4 POLARIS QUANTUM BIOTECH
  • 13.2.5 QSIMULATE

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS